Publications by authors named "Gamze Varan"

Claim this Profile
O
Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin Lymphoma.
Nurbanu Demirtürk, Gamze Varan, Sadık Kağa, Milo Malanga, Erem Bilensoy

Int J Pharm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles' Biodistribution in Cancer.
Sibel Goksen, Gamze Varan, Erem Bilensoy, Gunes Esendagli

Mol Pharm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and evaluation of chitosan gel containing metformin-loaded polymeric nanoparticles for topical treatment of melanoma.
Ziyneti Eke, Dilara Orgul, Gamze Varan, Nazlı Erdoğar

Drug Dev Ind Pharm· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors.
Sedat Ünal, Gamze Varan, Juan M Benito, Yeşim Aktaş, Erem Bilensoy

Beilstein J Org Chem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer.
Safiye Akkın, Gamze Varan, Anıl Işık, Sibel Gökşen, Elif Karakoç

Pharmaceutics· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU.
Safiye Akkın, Gamze Varan, Davut Aksüt, Milo Malanga, Ayşe Ercan

Int J Pharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib complexation with randomly methylated -cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer.
Nazlı Erdoğar, Safiye Akkın, Gamze Varan, Erem Bilensoy

Pharm Dev Technol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers.
Safiye Akkın, Gamze Varan, Erem Bilensoy

Molecules· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver.
Gamze Varan, Safiye Akkın, Nurbanu Demirtürk, Juan M Benito, Erem Bilensoy

J Drug Target· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level.
Ayse Ercan, Mustafa Çelebier, Selin Oncul, Gamze Varan, Engin Kocak

Int J Pharm· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo.
Gamze Varan, Cem Varan, Süleyman Can Öztürk, Juan M Benito, Güneş Esendağlı

Nanomaterials (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells.
Ayşe Ercan, Mustafa Çelebier, Gamze Varan, Selin Öncül, Merve Nenni

Eur J Pharm Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular Interaction and Tumoral Penetration Properties of Cyclodextrin Nanoparticles on 3D Breast Tumor Model.
Gamze Varan, Viorica Patrulea, Gerrit Borchard, Erem Bilensoy

Nanomaterials (Basel)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphiphilic cyclodextrin nanoparticles.
Gamze Varan, Cem Varan, Nazlı Erdoğar, A Atilla Hıncal, Erem Bilensoy

Int J Pharm· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
Nazlı Erdogar, Gamze Varan, Erem Bilensoy

Curr Top Med Chem· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.
Gamze Varan, Juan M Benito, Carmen Ortiz Mellet, Erem Bilensoy

Beilstein J Nanotechnol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles.
Gamze Varan, Selin Öncül, Ayşe Ercan, Juan M Benito, Carmen Ortiz Mellet

J Pharm Sci· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis